Zhou Jian-Wei, Cheng Qi, Xie Xing, Chen Huai-Zeng, Ye Da-Feng, Lu Wei-Guo
Department of Gynecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310006, PR China.
Ai Zheng. 2004 May;23(5):573-6.
BACKGROUND & OBJECTIVE: As a multifunctional Th2-cytokine, interleukin-10 (IL-10)plays a major role in the immune response. It is well known that IL-10 is an immunosuppressive cytokine, and participates in the development and progression of various tumors. In this study, we investigated the relationship between the IL-10 level in the ascites of the patients with primary ovarian epithelial carcinoma (POEC) and immune defect in the peritoneal cavity.
The IL-10 levels in serum and ascites of 32 patients with POEC, in culture supernatants of 4 different ovarian carcinoma cell lines and in serum of 10 patients with ovarian epithelial benign tumor and 10 health women (control) were measured by enzyme-linked immunosorbent assay (ELISA).
(1) IL-10 level in ascites was significantly higher than that in serum of patients with POEC, (159.78+/-51.20 ng/L vs 12.01+/-4.38 ng/L, P=0.000). IL-10 level in serum of the patients with POEC (12.01+/-4.38 ng/L) was significantly higher than that of the patients with benign tumor (3.79+/-2.40 ng/L, P=0.000) and control (4.45+/-2.69 ng/L, P=0.003). There was no significant difference of IL-10 level in serum between ovarian benign tumor and control (P=0.529). (2) IL-10 level in ascites of the patients with POEC was correlated with FIGO stage but not correlated with histological grade. (3) IL-10 was detectable in culture supernatants of 4 different ovarian cancer cell lines (3ao, SKOV3, CAOV3 and OVCAR).
High level of IL-10 in ascites of the patients with POEC is probably associated with immune defect in their peritoneal cavity, ovarian cancer cells may promote metastasis in peritoneal cavity by secreting IL-10.
白细胞介素-10(IL-10)作为一种多功能的Th2细胞因子,在免疫反应中起主要作用。众所周知,IL-10是一种免疫抑制细胞因子,参与各种肿瘤的发生和发展。在本研究中,我们调查了原发性卵巢上皮癌(POEC)患者腹水中IL-10水平与腹腔免疫缺陷之间的关系。
采用酶联免疫吸附测定(ELISA)法检测32例POEC患者血清和腹水中的IL-10水平、4种不同卵巢癌细胞系培养上清液中的IL-10水平,以及10例卵巢上皮性良性肿瘤患者和10例健康女性(对照组)血清中的IL-10水平。
(1)POEC患者腹水中IL-10水平显著高于血清中的水平(159.78±51.20 ng/L对12.01±4.38 ng/L,P=0.000)。POEC患者血清中IL-10水平(12.01±4.38 ng/L)显著高于良性肿瘤患者(3.79±2.40 ng/L,P=0.000)和对照组(4.45±2.69 ng/L,P=0.003)。卵巢良性肿瘤患者与对照组血清中IL-10水平无显著差异(P=0.529)。(2)POEC患者腹水中IL-10水平与国际妇产科联盟(FIGO)分期相关,但与组织学分级无关。(3)在4种不同卵巢癌细胞系(3ao、SKOV3、CAOV3和OVCAR)的培养上清液中可检测到IL-10。
POEC患者腹水中高水平的IL-10可能与其腹腔免疫缺陷有关,卵巢癌细胞可能通过分泌IL-10促进腹腔转移。